论文部分内容阅读
目的探讨经尿道电切术(TUR)在泌尿外科中的临床应用价值。方法采用TUR治疗151例泌尿外科病例,其中良性前列腺增生(BPH)123例,腺性膀胱炎13例,膀胱肿瘤7例,前列腺硬化症3例,电切术后前列腺段疤痕狭窄的3例,前列腺癌2例。术后随访3～24个月。结果本组151例病例,前列腺疾病的87例获随访,最大尿流率(Qmax)术前为(4.07±3.07)mL/s,术后3个月为(19.74±2.41)mL/s,国际前列腺的症状评分(I-PSS)术前为(27.55±4.07)分,术后3个月为(6.18±2.63)分,生活质量评分术前为(4.28±0.54),术后为(0.84±0.45),三项指标手术前后比较差异均有显著性(P<0.001);腺性膀胱炎和膀胱肿瘤共20例,术后每3、6、12、24个月复查一次,未见复发。结论TUR治疗是一种微创、安全、有效、可靠的治疗方法,值得在泌尿外科领域广泛推广应用。
Objective To investigate the clinical value of transurethral resection (TUR) in urology. Methods TUR was used to treat 151 cases of urological diseases, including 123 cases of benign prostatic hyperplasia (BPH), 13 cases of cystitis glandularis, 7 cases of bladder tumor, 3 cases of benign prostatic hyperplasia, 3 cases of scarred sutures after prostatectomy, Prostate cancer in 2 cases. The patients were followed up for 3 to 24 months. Results A total of 151 cases of this group and 87 cases of prostate disease were followed up. The maximal flow rate (Qmax) was (4.07 ± 3.07) mL / s preoperatively and (19.74 ± 2.41) mL / s 3 months postoperatively. Prostate symptom score (I-PSS) was (27.55 ± 4.07) before surgery, and (6.18 ± 2.63) at 3 months after surgery. The quality of life score was (4.28 ± 0.54) preoperatively and (0.84 ± 0.45). There were significant differences between the three indexes before and after surgery (P <0.001). There were 20 cases of cystitis glandula and bladder tumor. No recurrence was found every 3, 6, 12 and 24 months after operation. Conclusion TUR is a minimally invasive, safe, effective and reliable method of treatment. It is worth to be widely applied in the field of urology.